Savara (SVRA) Current Deferred Revenue (2018 - 2020)
Savara (SVRA) reported Current Deferred Revenue of $243000.0 for Q2 2020, up 2.1% on a QoQ basis from $238000.0 in Q1 2020.
Savara (SVRA) has 3 years of Current Deferred Revenue data on file, last reported at $243000.0 in Q2 2020.
- Quarterly Current Deferred Revenue changed N/A year-over-year to $243000.0 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $243000.0 (changed N/A YoY) and the FY2018 annual result came in at $250000.0, changed N/A from the prior year.
- Current Deferred Revenue improved to $243000.0 in Q2 2020 per SVRA's latest filing, from $238000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $250000.0 in Q4 2018 and bottomed at $238000.0 in Q1 2020.
- The 3-year median for Current Deferred Revenue is $242500.0 (2019), against an average of $243250.0.
- Peak annual rise in Current Deferred Revenue reached 1.65% in 2020, while the deepest fall reached 1.65% in 2020.
- Tracing SVRA's Current Deferred Revenue over 3 years: stood at $250000.0 in 2018, then retreated by 3.2% to $242000.0 in 2019, then climbed by 0.41% to $243000.0 in 2020.
- Per Business Quant, the three latest SVRA Current Deferred Revenue figures stand at $243000.0 (Q2 2020), $238000.0 (Q1 2020), and $242000.0 (Q1 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 243,000.00 |
| Mar 31, 2020 | 238,000.00 |
| Mar 31, 2019 | 242,000.00 |
| Dec 31, 2018 | 250,000.00 |